Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2009 Apr;49(4):1335-74.
doi: 10.1002/hep.22759.

Diagnosis, management, and treatment of hepatitis C: an update

Collaborators, Affiliations
Practice Guideline

Diagnosis, management, and treatment of hepatitis C: an update

Marc G Ghany et al. Hepatology. 2009 Apr.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Graphic display of virological responses. RVR, rapid virological response (clearance of HCV from serum by week 4 using a sensitive PCR-based assay); EVR, early virological response (≥2 log reduction in HCV RNA level compared to baseline HCV RNA level or HCV RNA negative at treatment week 12); SVR, sustained virological response (HCV RNA negative 24 weeks after cessation of treatment); relapse, reappearance of HCV RNA in serum after therapy is discontinued; nonresponder, failure to clear HCV RNA from serum after 24 weeks of therapy; partial nonresponder, 2 log decrease in HCV RNA but still HCV RNA positive at week 24; null nonresponder, failure to decrease HCV RNA by < 2 logs after 24 week of therapy.
Figure 2
Figure 2
Virological responses to pegylated interferon and ribavirin in the two U.S. Registration trials., ETR, end-of-treatment response; SVR, sustained virological response.
Figure 3
Figure 3
Treatment algorithm for managing and treating patients with chronic HCV infection, genotype 1. SVR, sustained virologic response; EVR, early virologic response. RVR is omitted from this treatment algorithm because it has not yet been adequately evaluated. HCV RNA should be quantitated using a sensitive assay (10–50 IU/mL).
Figure 4
Figure 4
Treatment algorithm for managing and treating patients with chronic HCV infection, genotype 2 or 3. EVR, early virologic response; ETR, end of treatment response; SVR, sustained virologic response. RVR is omitted from this treatment algorithm because it has not yet been adequately evaluated. HCV RNA should be quantitated using a sensitive assay (10–50 IU/mL).

Comment in

Similar articles

Cited by

References

    1. Eddy D A manual for assessing health practices and designing practice guidelines. Philadelphia: American College of Physicians; 1996: 1– 126.
    1. American Gastroenterological Association policy statement on the use of medical practice guidelines by managed care organizations and insurance carriers. Gastroenterology 1995; 108: 925– 926. - PubMed
    1. http://www.heart.org/presenter.jhtml?identifier=3039683 MMfAApAaa.
    1. Shiffman RN, Shekelle P, Overhage JM, Slutsky J, Grimshaw J, Deshpande AM. Standardized reporting of clinical practice guidelines: a proposal from the Conference on Guideline Standardization. Ann Intern Med 2003; 139: 493– 498. - PubMed
    1. Williams R Global challenges in liver disease. HEPATOLOGY 2006; 44: 521– 526. - PubMed

Publication types